Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Friday 1 November 2024, 01:00 AM
14 minutes to Read
More aggressive secondary prevention of cardiovascular disease now funded
+Educate
In print
Cardiovascular health
More aggressive secondary prevention of cardiovascular disease now funded
Friday 1 April 2022, 12:45 AM
[Image: iStock.com – Rasi Bhadramani]
Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Key points, Rosuvastatin 40mg will lower the LDL cholesterol level by approximately 63 per cent, compared with about 55 per cent with atorvastatin 80mg.
Ezetimi, Education Blue W/ Grey Background W/ Padding
References
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):11188.
Class
Hosted Content 2
Chemist Warehouse is sponsoring the Young Pharmacist of the Year Award in the 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora. The Chemist Warehouse leadership team explains what it means to be a Stellar Supporter
Thursday 20 February 2025, 08:03 AM
1 minute to Read
Latest issue
